# METHSCOPOLAMINE BROMIDE
> **ANDA216786** · Abbreviated New Drug Application (Generic) · Sponsor: NE RX PHARMA · Approved 2024-02-01
## Drug
- **FDA Application Number:** ANDA216786
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHSCOPOLAMINE BROMIDE
- **Generic name:** METHSCOPOLAMINE BROMIDE
- **Active ingredients:** METHSCOPOLAMINE BROMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NE RX PHARMA
- **Manufacturer:** i3 Pharmaceuticals, LLC
- **First approval:** 2024-02-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216786)
---
*MORVS · CC0 1.0*